Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Gentile

Showing results (261-270 of 313) with videos related to

Pageof 32
Sort By:
Hematological Oncology|May 31, 2022
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trialsEnrica Antonia Martino, Concetta Conticello, Elena Zamagni, et al.
Blood Advances|September 29, 2021
FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunologyCirino Botta, Catarina Maia, Juan-José Garcés, et al.
Haematologica|October 5, 2019
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemiaJared A Cohen, Francesca Maria Rossi, Antonella Zucchetto, et al.
American Journal of Hematology|October 10, 2012
Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemiaSonia Fabris, Laura Mosca, Giovanna Cutrona, et al.
Leukemia|June 25, 2025
Richter transformation in diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia receiving ibrutinib: risk factors and outcomesSara Pepe, Candida Vitale, Diana Giannarelli, et al.
Blood|February 2, 2020
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expressionErika Tissino, Federico Pozzo, Dania Benedetti, et al.
Cancers|September 9, 2023
Outcome of Second Primary Malignancies Developing in Multiple Myeloma PatientsIrit Avivi, David H Vesole, Julio Davila-Valls, et al.
Science Translational Medicine|February 16, 2018
Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolenceGiovanna Cutrona, Claudio Tripodo, Serena Matis, et al.
American Journal of Hematology|November 26, 2013
Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched studyFortunato Morabito, Sara Bringhen, Alessandra Larocca, et al.
American Journal of Hematology|April 7, 2022
Monoclonal gammopathy of renal significance (MGRS): Real-world data on outcomes and prognostic factorsAlessandro Gozzetti, Andrea Guarnieri, Elena Zamagni, et al.
Pageof 32

Showing results (261-270 of 313) with videos related to

Sort By:
Pageof 32
Hematological Oncology|May 31, 2022
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trialsEnrica Antonia Martino, Concetta Conticello, Elena Zamagni, et al.
Blood Advances|September 29, 2021
FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunologyCirino Botta, Catarina Maia, Juan-José Garcés, et al.
Haematologica|October 5, 2019
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemiaJared A Cohen, Francesca Maria Rossi, Antonella Zucchetto, et al.
American Journal of Hematology|October 10, 2012
Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemiaSonia Fabris, Laura Mosca, Giovanna Cutrona, et al.
Leukemia|June 25, 2025
Richter transformation in diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia receiving ibrutinib: risk factors and outcomesSara Pepe, Candida Vitale, Diana Giannarelli, et al.
Blood|February 2, 2020
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expressionErika Tissino, Federico Pozzo, Dania Benedetti, et al.
Cancers|September 9, 2023
Outcome of Second Primary Malignancies Developing in Multiple Myeloma PatientsIrit Avivi, David H Vesole, Julio Davila-Valls, et al.
Science Translational Medicine|February 16, 2018
Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolenceGiovanna Cutrona, Claudio Tripodo, Serena Matis, et al.
American Journal of Hematology|November 26, 2013
Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched studyFortunato Morabito, Sara Bringhen, Alessandra Larocca, et al.
American Journal of Hematology|April 7, 2022
Monoclonal gammopathy of renal significance (MGRS): Real-world data on outcomes and prognostic factorsAlessandro Gozzetti, Andrea Guarnieri, Elena Zamagni, et al.
Pageof 32